MONDAY, MAY 22, 2017

Experimental vaccine protects against norovirus

Researchers have found that an experimental vaccine protected people from norovirus during a small study involving 77 healthy men and women. Read More »

Cocooning approved by doctor group

A large group of U.S. doctors on Monday approved a process called cocooning, which allows pediatricians to offer vaccines to close family members of babies who are too young to get shots themselves. Read More »

Candidate vaccine eliminates the deadliest strains of malaria

British scientists have developed a candidate vaccine that has shown the potential to eliminate all of the strains of the deadliest form of the malaria parasite. Read More »

Researchers reveal the mechanism behind antigenic drift

A new study by researchers from the Massachusetts Institute of Technology has revealed the mechanism behind the phenomenon known as antigenic drift. Read More »

Maine reports first case of seasonal influenza

Public health officials in Maine have announced the state's first case of seasonal influenza as they continue to monitor a novel strain associated with pigs that sickened two children in October. Read More »

Microbes on human skin found to attract mosquitoes

According to research led by Niels Verhulst of Wageningen University in the Netherlands, the microbes on human skin determines how attracted mosquitoes are, which may have important implications for malaria transmission and prevention. Read More »

New Zealand doubles spending on measles vaccines

The New Zealand Ministry of Health recently reported spending almost double the normal amount on purchases of the measles vaccine this year. Read More »

Multidrug-resistant tuberculosis could be caused by faster drug metabolism

A new study demonstrated that multidrug-resistant tuberculosis is more likely caused by a faster drug metabolism in patients rather than the administration of inconsistent dosages of antibiotics. Read More »

CDC issues documents on identifying, reporting novel influenza viruses

In response to the recent confirmation of influenza infections with a novel variant of the H3N2 virus, the U.S. Centers for Disease Control and Prevention issued a new set of documents to advise healthcare workers on identifying and reporting new cases. Read More »

Cholera outbreak in the Democractic Republic of Congo waning

A cholera outbreak in the Democratic Republic of the Congo appears to be exhausting itself in the worst-affected areas, but new cases are being reported in other regions. Read More »

Texas court orders man to be treated for TB

A Nacogdoches, Texas, man has been court-ordered to the Texas Institute for Infectious Disease in San Antonio due to his potentially contagious case of tuberculosis. Read More »

Oseltamivir-resistant flu virus reported in Australia

According to a letter to the editor published in the New England Journal of Medicine, a variation of the pandemic H1N1 influenza virus that is resistant to oseltamivir appears to be spreading in Australia. Read More »

Emergent BioSolutions, Inc., announces plans for its TRU-016 program

Emergent BioSolutions, Inc., has announced plans for its TRU-016 program after receiving notice from Abbott that it will be terminating its co-development and co-commercializations agreement. Read More »

Emergent BioSolutions, Inc., initiates Phase 2 study of TRU-016

Emergent BioSolutions, Inc., has initiated a Phase 2 study of TRU-016 in combination with bendamustine for patients with relapsed chronic lymphocytic leukemia. Read More »